G Mark Foletta
Affiliations
- Director at Dexcom Inc (DXCM), 2024-06-20
- Director at Amn Healthcare Services Inc (AMN), 2024-04-23
- Director at Enanta Pharmaceuticals Inc (ENTA), 2024-03-08
- Evp & Chief Financial Officer at Tocagen Inc (TOCA), 2019-10-05
- Director at Regulus Therapeutics Inc. (RGLS), 2017-12-07
- Interim Cfo at Biocept Inc (BIOC), 2015-09-02
- Director at Ambit Biosciences Corp (AMBI), 2014-11-12
- Svp, Chief Financial Officer at Amylin Pharmaceuticals Inc (AMLN), 2012-08-10
- Director at Anadys Pharmaceuticals Inc (ANDS), 2011-05-27
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| AMN | $56.90 | 500 | Director | 8,573 | 2024-02-29 | Filing | |
| TOCA | $4.30 | 5,000 | Officer | 15,042 | 2019-05-28 | Filing | |
| TOCA | $10.00 | 5,000 | Officer | 5,000 | 2017-04-19 | Filing | |
| RGLS | $7.64 | 10,000 | Director | 10,000 | 2015-08-13 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| DXCM | $117.25 | 299 | Director | 56,398 | 2024-06-18 | Filing | |
| DXCM | $116.75 | 3,007 | Director | 56,697 | 2024-06-18 | Filing | |
| DXCM | $117.77 | 475 | Director | 59,704 | 2024-06-17 | Filing | |
| DXCM | $117.16 | 2,212 | Director | 60,179 | 2024-06-17 | Filing | |
| DXCM | $115.18 | 7 | Director | 62,391 | 2024-06-17 | Filing |